Cargando…
Sensitization of lung cancer cells by altered dimerization of HSP27
Heat shock protein 27 (HSP27, HSPB1) induces resistance to anticancer drugs in various cancer types, including non-small cell lung cancer (NSCLC). Therefore, pharmacological inhibition of HSP27 in NSCLC may be a good strategy for anticancer therapy. Unlike other HSPs such as HSP90 and HSP70, small m...
Autores principales: | Choi, Byeol, Choi, Seul-Ki, Park, You Na, Kwak, Soo-Yeon, Lee, Hwa Jeong, Kwon, Youngjoo, Na, Younghwa, Lee, Yun-Sil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739644/ https://www.ncbi.nlm.nih.gov/pubmed/29285257 http://dx.doi.org/10.18632/oncotarget.22192 |
Ejemplares similares
-
Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules
por: Kim, Jee Hye, et al.
Publicado: (2016) -
Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers
por: Yoo, Hawon, et al.
Publicado: (2021) -
Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
por: Hwang, Soo-Yeon, et al.
Publicado: (2020) -
Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations
por: Choi, Seul-Ki, et al.
Publicado: (2022) -
HSP27 inhibitor attenuates radiation-induced pulmonary inflammation
por: Kim, Jee-Youn, et al.
Publicado: (2018)